The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Angel Cequier
Showing 1-20 of 23 articles
Sirolimus-eluting stents with ultrathin struts versus everolimus-eluting stents for patients undergoing percutaneous coronary intervention: final three-year results of the TALENT trial
de Winter RJ,
Zaman A,
Hara H,
Gao C,
Ono M,
Garg S,
Smits P,
Tonino P,
Hofma S,
Moreno R,
Choudhury A,
Petrov I,
Cequier A,
Colombo A,
Kaul U,
Onuma Y,
Serruys P
August 19, 2022 | 10.4244/EIJ-D-21-00766
Magnesium-based resorbable scaffold vs permanent metallic sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction: 3-year results of the MAGSTEMI randomised controlled trial
Ortega-Paz L,
Brugaletta S,
Gomez-Lara J,
Alfonso F,
Cequier A,
Romaní S,
Bordes P,
Serra A,
Iñiguez A,
Salinas P,
García del Blanco B,
Goicolea J,
Hernández-Antolín R,
Cuesta J,
Gómez-Hospital JA,
Sabaté M
August 5, 2022 | 10.4244/EIJ-D-21-00651
Thin- versus thick-strut polymer-free biolimus-eluting stents: the BioFreedom QCA randomised trial
Sabaté M,
Jensen L,
Tilsted H,
Moreno R,
García del Blanco B,
Macaya C,
Perez de Prado A,
Cequier A,
Pérez-Fuentes P,
Schütte D,
Costa R,
Stoll H,
Lassen J
June 25, 2021 | 10.4244/EIJ-D-20-01162
In-hospital outcomes of COVID-19 ST-elevation myocardial infarction patients
Rodríguez-Leor O,
Cid Alvarez A,
Perez de Prado A,
Rossello X,
Ojeda S,
Serrador A,
López-Palop R,
Martin-Moreiras J,
Rumoroso J,
Cequier A,
Ibáñez B,
Cruz-González I,
Romaguera R,
Moreno R
April 20, 2021 | 10.4244/EIJ-D-20-00935
Bioresorbable scaffolds versus permanent sirolimus-eluting stents in patients with ST-segment elevation myocardial infarction: vascular healing outcomes from the MAGSTEMI trial
Gomez-Lara J,
Ortega-Paz L,
Brugaletta S,
Cuesta J,
Romaní S,
Serra A,
Salinas P,
García del Blanco B,
Goicolea J,
Hernández-Antolín R,
Antuña P,
Romaguera R,
Regueiro A,
Rivero F,
Cequier A,
Alfonso F,
Gómez-Hospital JA,
Sabaté M
December 4, 2020 | 10.4244/EIJ-D-20-00198
Bioresorbable scaffolds versus everolimus-eluting metallic stents: five-year clinical outcomes of the randomised ABSORB II trial
Onuma Y,
Chevalier B,
Ono M,
Cequier A,
Dudek D,
Haude M,
Carrié D,
Sabaté M,
Windecker S,
Rapoza R,
West N,
Reith S,
de Sousa Almeida M,
Campo G,
Iñiguez A,
Serruys P
December 4, 2020 | 10.4244/EIJ-D-20-00024
Coronary vasomotor function and myocardial flow with bioresorbable vascular scaffolds or everolimus-eluting metallic stents: a randomised trial
Gomez-Lara J,
Salvatella N,
Romaguera R,
Brugaletta S,
Nato M,
Roura G,
Ferreiro J,
Teruel L,
Gracida M,
Sabaté M,
Vaquerizo B,
Cequier A,
Gomez-Hospital J
June 12, 2020 | 10.4244/EIJ-D-18-01203
Bioresorbable vascular scaffolds versus everolimus-eluting metallic stents in patients with ST-segment elevation myocardial infarction: 5-year results of the BVS-EXAMINATION study
Brugaletta S,
Gori T,
Tousek P,
Gomez-Lara J,
Pinar E,
Ortega-Paz L,
Schulz E,
Kocka V,
Munzel T,
Cequier A,
Buono A,
Serruys P,
Sabaté M
March 20, 2020 | 10.4244/EIJ-D-19-00773
Three-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and a durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction (TROFI II trial)
Katagiri Y,
Onuma Y,
Asano T,
Iñiguez A,
Jensen L,
Cequier A,
Hofma S,
Christiansen E,
Suttorp M,
Brugaletta S,
Räber L,
Sabaté M,
Windecker S,
Serruys P,
Räber L,
Sabaté M,
Serruys P
December 7, 2018 | 10.4244/EIJ-D-18-00839
Association between coronary atherosclerosis progression and in-stent neoatherosclerosis in patients with ST-elevation myocardial infarction at five-year follow-up
Paoletti G,
Gomez-Lara J,
Brugaletta S,
Nato M,
Romaguera R,
Roura G,
Ferreiro JL,
Teruel L,
Gracida M,
Ortega-Paz L,
Gomez-Hospital J,
Sabaté M,
Cequier A
June 20, 2018 | 10.4244/EIJ-D-17-00255
Invasive strategy and frailty in very elderly patients with acute coronary syndromes
Llao I,
Ariza-Sole A,
Sanchis J,
Alegre O,
López-Palop R,
Formiga F,
Marin F,
Vidan MT,
Martínez-Sellés M,
Sionis A,
Vives-Borras M,
Gomez-Hospital J,
Gomez-Lara J,
Roura G,
Díez-Villanueva P,
Núñez-Gil I,
Maristany J,
Asmarats L,
Bueno H,
Abu-Assi E,
Cequier A
June 14, 2018 | 10.4244/EIJ-D-18-00099
Correlates of non-target vessel-related adverse events in patients with ST-segment elevation myocardial infarction: insights from five-year follow-up of the EXAMINATION trial
Spitaleri G,
Moscarella E,
Brugaletta S,
Pernigotti A,
Ortega-Paz L,
Gomez-Lara J,
Cequier A,
Iñiguez A,
Serra A,
Jiménez-Quevedo P,
Mainar V,
Campo G,
Tespili M,
den Heijer P,
Bethencourt A,
Vázquez N,
Valgimigli M,
Serruys P,
Sabaté M
March 20, 2018 | 10.4244/EIJ-D-17-00608
Four-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II Trial)
Chevalier B,
Cequier A,
Dudek D,
Haude M,
Carrié D,
Sabaté M,
Windecker S,
Reith S,
de Sousa Almeida M,
Campo G,
Iñiguez A,
Onuma Y,
Serruys P
January 19, 2018 | 10.4244/EIJ-D-17-00873
Impact of stent overlapping on long-term clinical outcomes in patients with ST-segment elevation myocardial infarction: insights from the five-year follow-up of the EXAMINATION trial
Ortega-Paz L,
Brugaletta S,
Giacchi G,
Ishida K,
Cequier A,
Iñiguez A,
Serra A,
Jiménez-Quevedo P,
Mainar V,
Campo G,
Tespili M,
den Heijer P,
Valgimigli M,
Serruys P,
Sabaté M
August 4, 2017 | 10.4244/EIJ-D-16-00512
Impact of presentation and transfer delays on complete ST-segment resolution before primary percutaneous coronary intervention: insights from the ATLANTIC trial
Fabris E,
van't Hof A,
Hamm C,
Lapostolle F,
Lassen J,
Goodman S,
ten Berg J,
Bolognese L,
Cequier A,
Chettibi M,
Hammett C,
Huber K,
Janzon M,
Merkely B,
Storey R,
Zeymer U,
Cantor W,
Rousseau H,
Vicaut E,
Montalescot G
May 15, 2017 | 10.4244/EIJ-D-16-00965
IVUS-guided treatment strategies for definite late and very late stent thrombosis
Gomez-Lara J,
Salvatella N,
Gonzalo N,
Hernandez Hernandez F,
Fernández-Nofrerias E,
Sanchez Recalde A,
Bastante T,
Marcano A,
Romaguera R,
Ferreiro JL,
Roura G,
Teruel L,
Ariza-Sole A,
Miranda-Guardiola F,
Garcia-Abad V,
Gomez-Hospital J,
Alfonso F,
Cequier A
December 9, 2016 | 10.4244/EIJY15M12_08
Preserved endothelial vasomotor function after everolimus-eluting stent implantation
Roura G,
Homs S,
Ferreiro JL,
Gomez-Lara J,
Romaguera R,
Teruel L,
Sanchez-Elvira G,
Ariza-Sole A,
Gomez-Hospital J,
Cequier A
October 20, 2015 | 10.4244/EIJY14M07_09
Predictors of adverse events among patients undergoing primary percutaneous coronary intervention: insights from a pooled analysis of the COMFORTABLE AMI and EXAMINATION trials
Taniwaki M,
Stefanini G,
Räber L,
Brugaletta S,
Cequier A,
Heg D,
Iñiguez A,
Kelbæk H,
Serra A,
Ostojic M,
Hernández-Antolín R,
Baumbach A,
Blochlinger S,
Jüni P,
Mainar V,
Sabaté M,
Windecker S
August 20, 2015 | 10.4244/EIJY14M07_12
Rationale and design of the RIBS IV randomised clinical trial (drug-eluting balloons versus everolimus-eluting stents for patients with drug-eluting stent restenosis)
Alfonso F,
Pérez-Vizcayno M,
Cardenas A,
García del Blanco B,
García Touchard A,
Lopez-Minguez J,
Rivero F,
Masotti M,
Zueco J,
Cequier A,
Morís C,
Fernandez Ortiz A,
Escaned J,
Jiménez-Quevedo P,
Gonzalo N,
Fernandez C,
Macaya C
July 20, 2015 | 10.4244/EIJY14M09_07
Coronary perforation after bioresorbable vascular scaffold implantation
Gomez-Lara J,
Teruel L,
Romaguera R,
Roura G,
Ferreiro JL,
Sanchez-Elvira G,
Gomez-Hospital J,
Cequier A
April 20, 2015 | 10.4244/EIJV10I12A253
1
2
Latest news
NEW ISSUE
ESC/EAPCI Consensus Statement on Renal Denervation; the Future of TMVR; Mini-focus on Interventional Pharmacology...
March 20, 2023
AHEAD OF PRINT
Early changes in cardiac damage after TAVI
FREE ARTICLE - Yaoyao Zhou et al
March 17, 2023
AHEAD OF PRINT
Posterior pericardiotomy for the prevention of atrial fibrillation
FREE ARTICLE - Ahmed AbdelAziz et al
March 16, 2023
AHEAD OF PRINT
One-year outcomes with the Mistral device
FREE ARTICLE - Kerstin Piayda et al
March 13, 2023
AHEAD OF PRINT
Navitor CE mark cohort outcomes
FREE ARTICLE - Lars Sondergaard et al
March 9, 2023
AHEAD OF PRINT
One-year SAPIEN 3U registry results
FREE ARTICLE - Stefano Cannata et al
March 7, 2023
AHEAD OF PRINT
The POT-PUFF sign: an angiographic mark of stent malapposition during proximal optimisation
FREE ARTICLE - Farhang Aminfar et al
March 3, 2023
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke